APA (7th ed.) Citation

Lee, J., Choi, E., Han, B., Kim, J., Jung, D., Kim, K., . . . Kim, S. (2025). Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00707-7

Chicago Style (17th ed.) Citation

Lee, Juheon, et al. "Tumor-priming CD8+ Natural Killer T-like Cells as an Efficient Novel Cell Therapy for Relapsed/refractory Multiple Myeloma." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00707-7.

MLA (9th ed.) Citation

Lee, Juheon, et al. "Tumor-priming CD8+ Natural Killer T-like Cells as an Efficient Novel Cell Therapy for Relapsed/refractory Multiple Myeloma." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00707-7.